PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BTEC vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BTEC and ARKG is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.8

Performance

BTEC vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Principal Healthcare Innovators Index ETF (BTEC) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

30.00%40.00%50.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
57.13%
34.88%
BTEC
ARKG

Key characteristics

Returns By Period


BTEC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

ARKG

YTD

-27.83%

1M

1.37%

6M

-2.83%

1Y

-26.09%

5Y*

-7.08%

10Y*

1.96%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BTEC vs. ARKG - Expense Ratio Comparison

BTEC has a 0.42% expense ratio, which is lower than ARKG's 0.75% expense ratio.


ARKG
ARK Genomic Revolution Multi-Sector ETF
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for BTEC: current value at 0.42% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.42%

Risk-Adjusted Performance

BTEC vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Principal Healthcare Innovators Index ETF (BTEC) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BTEC, currently valued at 0.89, compared to the broader market0.002.004.000.89-0.59
The chart of Sortino ratio for BTEC, currently valued at 1.38, compared to the broader market-2.000.002.004.006.008.0010.001.38-0.66
The chart of Omega ratio for BTEC, currently valued at 1.20, compared to the broader market0.501.001.502.002.503.001.200.93
The chart of Calmar ratio for BTEC, currently valued at 0.34, compared to the broader market0.005.0010.0015.000.34-0.30
The chart of Martin ratio for BTEC, currently valued at 3.00, compared to the broader market0.0020.0040.0060.0080.00100.003.00-1.00
BTEC
ARKG


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
0.89
-0.59
BTEC
ARKG

Dividends

BTEC vs. ARKG - Dividend Comparison

Neither BTEC nor ARKG has paid dividends to shareholders.


TTM2023202220212020201920182017
BTEC
Principal Healthcare Innovators Index ETF
0.00%0.00%0.00%0.96%0.37%0.00%0.00%0.13%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

BTEC vs. ARKG - Drawdown Comparison


-80.00%-70.00%-60.00%-50.00%-40.00%JulyAugustSeptemberOctoberNovemberDecember
-43.68%
-78.81%
BTEC
ARKG

Volatility

BTEC vs. ARKG - Volatility Comparison

The current volatility for Principal Healthcare Innovators Index ETF (BTEC) is 0.00%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 14.47%. This indicates that BTEC experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember0
14.47%
BTEC
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab